DEXCEL PHARMA TECHNOLOGIES LTD.
18Patents
16Active
18Granted
46Portfolio score
Filing activity: Jun 4, 1999 → Jul 30, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6531152B1 | Immediate release gastrointestinal drug delivery system | Human Necessities | 133 | Expired |
| US6632451B2 | Delayed total release two pulse gastrointestinal drug delivery system | Emerging Cross-Sectional Technologies | 79 | Expired |
| US10076494B2 | Stable orally disintegrating pharmaceutical compositions | Human Necessities | 10 | Active |
| US8865198B2 | Method for treating a periodontal disease | Human Necessities | 2 | Active |
| US9278064B2 | Method for treating a periodontal disease | Human Necessities | 1 | Active |
| US11304961B2 | Compositions comprising dexamethasone | Human Necessities | 1 | Active |
| US9889090B2 | Method for treating a periodontal disease | Human Necessities | 0 | Active |
| US10736855B2 | Compositions comprising proton pump inhibitors | Human Necessities | 0 | Active |
| US9757338B2 | Sustained-release donepezil formulation | Human Necessities | 0 | Active |
| US11096948B2 | Methods for treating helicobacter infection | Human Necessities | 0 | Active |
| US11077055B2 | Orally disintegrating compositions | Human Necessities | 0 | Active |
| US11299583B2 | Alternating and semi-alternating poly(ester-anhydride) copolymers | Human Necessities | 0 | Active |
| US10172882B2 | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof | Human Necessities | 0 | Active |
| US11141488B2 | Compositions comprising biodegradable copolymers for prolonged local release of an antibiotic | Chemistry; Metallurgy | 0 | Active |
| US10835488B2 | Stable orally disintegrating pharmaceutical compositions | Human Necessities | 0 | Active |
| US11986554B2 | Orally disintegrating compositions | Human Necessities | 0 | Active |
| US10774176B2 | Alternating and semi-alternating poly(ester-anhydride) copolymers | Human Necessities | 0 | Active |
| US10537585B2 | Compositions comprising dexamethasone | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.